nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Trauma—Prednisolone—psoriatic arthritis	0.0266	0.0266	CcSEcCtD
Methocarbamol—Trauma—Triamcinolone—psoriatic arthritis	0.0245	0.0245	CcSEcCtD
Methocarbamol—Trauma—Methylprednisolone—psoriatic arthritis	0.0244	0.0244	CcSEcCtD
Methocarbamol—Taste metallic—Methotrexate—psoriatic arthritis	0.0242	0.0242	CcSEcCtD
Methocarbamol—Trauma—Betamethasone—psoriatic arthritis	0.0222	0.0222	CcSEcCtD
Methocarbamol—Trauma—Dexamethasone—psoriatic arthritis	0.0222	0.0222	CcSEcCtD
Methocarbamol—Jaundice—Auranofin—psoriatic arthritis	0.0217	0.0217	CcSEcCtD
Methocarbamol—Conjunctivitis—Auranofin—psoriatic arthritis	0.0216	0.0216	CcSEcCtD
Methocarbamol—Trauma—Prednisone—psoriatic arthritis	0.0193	0.0193	CcSEcCtD
Methocarbamol—Dysgeusia—Auranofin—psoriatic arthritis	0.017	0.017	CcSEcCtD
Methocarbamol—Angioedema—Auranofin—psoriatic arthritis	0.0159	0.0159	CcSEcCtD
Methocarbamol—Leukopenia—Auranofin—psoriatic arthritis	0.0156	0.0156	CcSEcCtD
Methocarbamol—Dyspepsia—Auranofin—psoriatic arthritis	0.0125	0.0125	CcSEcCtD
Methocarbamol—Urticaria—Auranofin—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Methocarbamol—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Methocarbamol—Pruritus—Auranofin—psoriatic arthritis	0.01	0.01	CcSEcCtD
Methocarbamol—Injury—Prednisolone—psoriatic arthritis	0.01	0.01	CcSEcCtD
Methocarbamol—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.00977	0.00977	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.00975	0.00975	CcSEcCtD
Methocarbamol—Injury—Triamcinolone—psoriatic arthritis	0.00921	0.00921	CcSEcCtD
Methocarbamol—Injury—Methylprednisolone—psoriatic arthritis	0.00919	0.00919	CcSEcCtD
Methocarbamol—Vomiting—Auranofin—psoriatic arthritis	0.00902	0.00902	CcSEcCtD
Methocarbamol—Amnesia—Methylprednisolone—psoriatic arthritis	0.00899	0.00899	CcSEcCtD
Methocarbamol—Rash—Auranofin—psoriatic arthritis	0.00894	0.00894	CcSEcCtD
Methocarbamol—Dermatitis—Auranofin—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Methocarbamol—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.00887	0.00887	CcSEcCtD
Methocarbamol—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.00887	0.00887	CcSEcCtD
Methocarbamol—Nausea—Auranofin—psoriatic arthritis	0.00842	0.00842	CcSEcCtD
Methocarbamol—Injury—Betamethasone—psoriatic arthritis	0.00835	0.00835	CcSEcCtD
Methocarbamol—Injury—Dexamethasone—psoriatic arthritis	0.00835	0.00835	CcSEcCtD
Methocarbamol—Thrombophlebitis—Prednisone—psoriatic arthritis	0.00772	0.00772	CcSEcCtD
Methocarbamol—Injury—Prednisone—psoriatic arthritis	0.00727	0.00727	CcSEcCtD
Methocarbamol—Amnesia—Prednisone—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Methocarbamol—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00689	0.00689	CcSEcCtD
Methocarbamol—Bradycardia—Prednisolone—psoriatic arthritis	0.00648	0.00648	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00646	0.00646	CcSEcCtD
Methocarbamol—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00634	0.00634	CcSEcCtD
Methocarbamol—Bradycardia—Triamcinolone—psoriatic arthritis	0.00596	0.00596	CcSEcCtD
Methocarbamol—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00595	0.00595	CcSEcCtD
Methocarbamol—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Methocarbamol—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Methocarbamol—Bradycardia—Betamethasone—psoriatic arthritis	0.00541	0.00541	CcSEcCtD
Methocarbamol—Bradycardia—Dexamethasone—psoriatic arthritis	0.00541	0.00541	CcSEcCtD
Methocarbamol—Vision blurred—Prednisolone—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Methocarbamol—Angioedema—Prednisolone—psoriatic arthritis	0.00506	0.00506	CcSEcCtD
Methocarbamol—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00499	0.00499	CcSEcCtD
Methocarbamol—Vertigo—Prednisolone—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Methocarbamol—Syncope—Prednisolone—psoriatic arthritis	0.00497	0.00497	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Methocarbamol—Convulsion—Prednisolone—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Methocarbamol—Bradycardia—Prednisone—psoriatic arthritis	0.00471	0.00471	CcSEcCtD
Methocarbamol—Angioedema—Triamcinolone—psoriatic arthritis	0.00466	0.00466	CcSEcCtD
Methocarbamol—Angioedema—Methylprednisolone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Methocarbamol—Vertigo—Triamcinolone—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Methocarbamol—Syncope—Triamcinolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Methocarbamol—Vertigo—Methylprednisolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Methocarbamol—Syncope—Methylprednisolone—psoriatic arthritis	0.00456	0.00456	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Methocarbamol—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Methocarbamol—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Methocarbamol—Shock—Prednisolone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Methocarbamol—Convulsion—Triamcinolone—psoriatic arthritis	0.00442	0.00442	CcSEcCtD
Methocarbamol—Convulsion—Methylprednisolone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Methocarbamol—Drowsiness—Methotrexate—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Methocarbamol—Flushing—Prednisone—psoriatic arthritis	0.00429	0.00429	CcSEcCtD
Methocarbamol—Angioedema—Betamethasone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Methocarbamol—Angioedema—Dexamethasone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Methocarbamol—Confusional state—Methylprednisolone—psoriatic arthritis	0.00418	0.00418	CcSEcCtD
Methocarbamol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00416	0.00416	CcSEcCtD
Methocarbamol—Vertigo—Betamethasone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Methocarbamol—Vertigo—Dexamethasone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Methocarbamol—Syncope—Dexamethasone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Methocarbamol—Syncope—Betamethasone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Methocarbamol—Shock—Triamcinolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Methocarbamol—Insomnia—Prednisolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Methocarbamol—Shock—Methylprednisolone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Methocarbamol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Methocarbamol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Methocarbamol—Convulsion—Betamethasone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Methocarbamol—Convulsion—Dexamethasone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Methocarbamol—Hypotension—Methylprednisolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Methocarbamol—Pain—Prednisolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Methocarbamol—Vision blurred—Prednisone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Methocarbamol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Methocarbamol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Methocarbamol—Insomnia—Triamcinolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Methocarbamol—Insomnia—Methylprednisolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Methocarbamol—Shock—Dexamethasone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Methocarbamol—Shock—Betamethasone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Methocarbamol—Angioedema—Prednisone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Methocarbamol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Methocarbamol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Methocarbamol—Vertigo—Prednisone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Methocarbamol—Syncope—Prednisone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Methocarbamol—Urticaria—Prednisolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Methocarbamol—Pain—Triamcinolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Methocarbamol—Hypotension—Dexamethasone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Methocarbamol—Hypotension—Betamethasone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Methocarbamol—Convulsion—Prednisone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Methocarbamol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Methocarbamol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Methocarbamol—Insomnia—Betamethasone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Methocarbamol—Insomnia—Dexamethasone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Methocarbamol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Methocarbamol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Methocarbamol—Urticaria—Triamcinolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Methocarbamol—Urticaria—Methylprednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Methocarbamol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Methocarbamol—Shock—Prednisone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Methocarbamol—Pain—Dexamethasone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Methocarbamol—Pain—Betamethasone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Methocarbamol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Methocarbamol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Methocarbamol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Methocarbamol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Methocarbamol—Urticaria—Dexamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Methocarbamol—Urticaria—Betamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Methocarbamol—Dizziness—Prednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Methocarbamol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Methocarbamol—Body temperature increased—Betamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Methocarbamol—Insomnia—Prednisone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Methocarbamol—Pruritus—Triamcinolone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Methocarbamol—Pruritus—Methylprednisolone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Methocarbamol—Dyspepsia—Prednisone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Methocarbamol—Rash—Prednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Methocarbamol—Dermatitis—Prednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Methocarbamol—Headache—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Methocarbamol—Dizziness—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Methocarbamol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Methocarbamol—Nausea—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Methocarbamol—Pruritus—Betamethasone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Methocarbamol—Pruritus—Dexamethasone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Methocarbamol—Vomiting—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Methocarbamol—Vomiting—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Methocarbamol—Rash—Triamcinolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Methocarbamol—Dermatitis—Triamcinolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Methocarbamol—Rash—Methylprednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Methocarbamol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Methocarbamol—Urticaria—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Methocarbamol—Headache—Triamcinolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Methocarbamol—Headache—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Methocarbamol—Body temperature increased—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Methocarbamol—Dizziness—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Methocarbamol—Dizziness—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Methocarbamol—Nausea—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Methocarbamol—Nausea—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Methocarbamol—Dyspepsia—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Methocarbamol—Vomiting—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Methocarbamol—Vomiting—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Methocarbamol—Rash—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Methocarbamol—Rash—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Methocarbamol—Dermatitis—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Methocarbamol—Dermatitis—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Methocarbamol—Headache—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Methocarbamol—Headache—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Methocarbamol—Pain—Methotrexate—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Methocarbamol—Pruritus—Prednisone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Methocarbamol—Nausea—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Methocarbamol—Nausea—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Methocarbamol—Dizziness—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Methocarbamol—Vomiting—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Methocarbamol—Rash—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Methocarbamol—Dermatitis—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Methocarbamol—Headache—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Methocarbamol—Nausea—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Methocarbamol—Rash—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Methocarbamol—Headache—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
